Leerink's David Risinger cheered the positive safety and eff...
Leerink's David Risinger cheered the positive safety and efficacy results in obese patients, but market reaction tainted Structure's acquisition prospects.
New Shakeup Hits Obesity Pills. Structure Rolls Out Disappointing Data. -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3374Followers
0Following
8168Visitors
Follow